|
The
Medication Resource Specialist
How to improve patients’ access to
drug therapies when funding is an issue
Victoria Sullivan, BN, RN, MHS, CON(C)
and Mary Lou Robertson, BA, BSW, RSW
Synoptic
reporting and the quality of cancer care
Standardized surgery and pathology reports will lead to consistently
better postoperative treatment decisions
Robin Urquhart, MSc; Eva Grunfeld,
MD, DPhil, FCFP; Geoffrey A. Porter, MD, FRCSC, FACS
Improving
the care of colorectal cancer patients
Report from the 10th annual Western Canadian Colorectal Cancer Consensus
Conference
Sheryl Koski, MD, FRCPC, MHPE et al
Access
to cancer drug funding in Canada
A report on possible ways to mend our fractured system
Emily Andrews and Susan Usher
Funded by an unrestricted grant from
sanofi-aventis Canada Inc.
|
Review
of important clinical trials with commentaries by Canadian experts
The 31st San Antonio Breast Cancer Symposium
Hormonal therapy in early
postmenopausal breast cancer
Debjani Grenier, MD, FRCPC
Zoledronic acid in women
receiving letrozole
Sunil Verma, MD, MSEd, FRCPC
and Danny Robson, MD, FRCPC
Lapatinib added to endocrine
therapy in metastatic breast cancer
Sunil Verma, MD, MSEd, FRCPC
and Danny Robson, MD, FRCPC
Using breast density to
predict tamoxifen efficacy in breast cancer prevention
Joseph Ragaz, MD, FRCPC
MSI
tests in Stage II colon cancer
Amil Shah, MDCM, FRCPC, FACP
The
6th Vital Sign in oncology
Barry D. Bultz, PhD and Shannon
L. Groff, BSc Psych
Professional
meetings roster
Your calendar dates for essential
conferences and symposia
New drugs and indications
A review of recent cancer therapy
approvals in Canada and the US
|
